AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Plandaí Biotechnology, Inc.

$0 +$0.00 (+9,900%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
4.49M
AVG Volume
2.45M
Trailing/Forward PE
-74.65/-
PEG ratio
-0.75
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
00.250.50.75123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
23 Q20
Net Income (USD) · TTM
-5M05M10M15M20M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
25 Q3-60.13K
25 Q2-75.97K
25 Q1-68.42K
24 Q4-57.45K
24 Q3-3.63M
24 Q2-3.4M
24 Q1-3.59M
23 Q416.03M
23 Q3-458.79K
23 Q2-925.83K
Operating Income (USD) · TTM
-4M-3M-2M-1M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
25 Q3-60.04K
25 Q2-75.92K
25 Q1-68.42K
24 Q4-57.45K
24 Q3-3.84M
24 Q2-3.61M
24 Q1-3.59M
23 Q4-3.59M
23 Q3-468.83K
23 Q2-699.84K
EBITDA (USD) · TTM
-5M05M10M15M20M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
25 Q3-60.04K
25 Q2-75.92K
25 Q1-68.42K
24 Q4-57.45K
24 Q3-3.42M
24 Q2-3.19M
24 Q1-3.38M
23 Q416.29M
23 Q3-354.54K
23 Q2-790.69K
Cash Flows (USD) · TTM
-5M05M10M15M20M15 Q315 Q416 Q116 Q216 Q322 Q423 Q123 Q223 Q323 Q4
PLPL Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q415.64M
23 Q3-182.3K
23 Q2-4.51K
23 Q1-4.46K
22 Q42
16 Q3-1.3M
16 Q2-1.47M
16 Q1-999.54K
15 Q4-1.08M
15 Q3-2.1M
EPS (USD) · TTM
-0000023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
25 Q30
25 Q20
25 Q10
24 Q40
24 Q3-0
24 Q2-0
24 Q1-0
23 Q40
23 Q30
23 Q2-0
Expenses (USD) · TTM
01M2M3M4MR&DSG&ACapex23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
PLPL Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q10
22 Q40
16 Q357.66K
16 Q250.83K
16 Q156.98K
15 Q411.54K
15 Q3116.15K
25 Q360.04K
25 Q275.92K
25 Q168.42K
24 Q457.45K
24 Q33.84M
24 Q23.83M
24 Q13.81M
23 Q43.81M
23 Q3685.76K
23 Q2699.54K
Shares Outstanding (USD) · TTM
-2M02M4MBuybacks (Repurchases)Stock-Based Compensation15 Q315 Q416 Q116 Q216 Q322 Q423 Q123 Q223 Q323 Q4
PLPL Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q43.93M
23 Q30
23 Q20
23 Q10
22 Q40
16 Q3-552.95K
16 Q2-420.8K
16 Q1-493.75K
15 Q4-273.35K
15 Q389.19K
Employee Count
0501001502002016
PLPL Employee Count by quarter
PeriodEmployee Count
2016180
PE Ratio
00.20.40.6med 0.29Jan 23Feb 23Mar 23Oct 24Nov 24Nov 24Dec 24
PLPL PE Ratio by quarter
PeriodPE Ratio
Dec 240
Dec 240.28
Dec 240.42
Dec 240.28
Nov 240.42
Nov 240.42
Nov 240.28
Nov 240.28
Nov 240.28
Oct 240.42
Oct 240.56
Oct 240.42
Oct 240.56
Mar 230.08
Mar 230.03
Mar 230.58
Mar 230.39
Feb 230.29
Feb 230.29
Feb 230.29
Feb 230.29
Jan 230.29
Jan 230.29
Jan 230.29
Jan 230.34
Dec 220.3
Free Cash Flow Yield
-10000%0%10000%20000%30000%40000%med -9.87%Apr 23Jul 23Nov 23Feb 24May 24Sep 24Dec 24
PLPL Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Dec 2434831.83%
Dec 24348.32%
Dec 24232.21%
Dec 24348.32%
Nov 24232.21%
Nov 24232.21%
Nov 24348.32%
Nov 24348.32%
Nov 24348.32%
Oct 24232.21%
Oct 24174.16%
Oct 24232.21%
Oct 24174.16%
Sep 24-20.51%
Sep 24-12.82%
Sep 24-20.51%
Sep 24-6.84%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-20.51%
Jul 24-13.67%
Jul 24-10.25%
Jul 24-10.25%
Jul 24-8.2%
Jun 24-0.27%
Jun 24-0.13%
Jun 24-0.15%
Jun 24-0.13%
May 24-0.13%
May 24-0.12%
May 24-0.11%
May 24-0.18%
May 24-0.15%
Apr 24-0.13%
Apr 24-0.11%
Apr 24-0.11%
Apr 24-0.53%
Mar 24-0.39%
Mar 24-0.54%
Mar 24-0.54%
Mar 24-0.54%
Mar 24-0.27%
Feb 24-0.36%
Feb 24-0.27%
Feb 24-0.27%
Feb 24-0.18%
Jan 24-0.18%
Jan 24-0.18%
Jan 24-0.27%
Jan 24-0.54%
Dec 23-0.27%
Dec 23-8.58%
Dec 23-12.87%
Dec 23-12.87%
Dec 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Oct 23-12.87%
Oct 23-8.58%
Oct 23-12.87%
Oct 23-12.87%
Sep 23-17.16%
Sep 23-59.68%
Sep 23-29.84%
Sep 23-39.78%
Sep 23-23.87%
Aug 23-29.84%
Aug 23-29.84%
Aug 23-29.84%
Aug 23-29.84%
Jul 23-14.92%
Jul 23-19.89%
Jul 23-14.92%
Jul 23-14.92%
Jun 23-14.92%
Jun 23-10.28%
Jun 23-9.49%
Jun 23-8.81%
Jun 23-7.81%
May 23-7.71%
May 23-6.86%
May 23-13.71%
May 23-13.71%
Apr 23-12.34%
Apr 23-11.22%
Apr 23-8.81%
Apr 23-10.28%
Mar 23-10.28%
Dec 17-24.61%
Dec 17-30.57%
Dec 17-36.46%
Dec 17-55.93%
Nov 17-79.39%
Nov 17-74.57%
Nov 17-76.31%
Nov 17-65.63%
Price to Sales
020406080med 8.62Jan 21Apr 21Aug 21Nov 21May 23Sep 23Dec 23
PLPL Price to Sales by quarter
PeriodPrice to Sales
Dec 2330.43
Dec 2320.29
Dec 2320.29
Dec 2320.29
Nov 2320.29
Nov 2320.29
Nov 2320.29
Nov 2320.29
Oct 2320.29
Oct 2330.43
Oct 2320.29
Oct 2320.29
Sep 2315.22
Sep 234.19
Sep 238.38
Sep 236.28
Sep 2310.47
Aug 238.38
Aug 238.38
Aug 238.38
Aug 238.38
Jul 2316.75
Jul 2312.56
Jul 2316.75
Jul 2316.75
Jun 2316.75
Jun 2324.28
Jun 2326.3
Jun 2328.32
Jun 2331.96
May 2332.37
May 2336.41
May 2318.21
May 2318.21
Apr 2320.23
Apr 2322.25
Apr 2328.32
Apr 2324.28
Mar 2324.28
Mar 230.97
Mar 231.06
Dec 2128.85
Dec 2128.85
Dec 2133.66
Dec 2121.64
Nov 2124.04
Nov 2124.04
Nov 2143.27
Nov 2143.27
Oct 2150.49
Oct 2162.51
Oct 2169.72
Oct 2162.51
Oct 2152.89
Sep 217.98
Sep 216.21
Sep 212.66
Sep 214.43
Aug 214.43
Aug 214.43
Aug 215.32
Aug 216.21
Jul 216.21
Jul 216.21
Jul 216.21
Jul 217.09
Jul 217.98
Jun 216.21
Jun 217.09
Jun 217.09
Jun 217.09
May 217.98
May 217.98
May 217.09
May 218.87
Apr 218.87
Apr 2110.64
Apr 218.87
Apr 2111.08
Apr 217.09
Mar 210.47
Mar 210.63
Mar 210.63
Mar 210.55
Feb 211.1
Feb 211.33
Feb 211.41
Feb 211.1
Jan 210.55
Jan 210.47
Jan 210.39
Jan 210.39
Dec 200.23
Dec 200.31
Dec 200.31
Dec 200.47
Dec 200.47
Nov 200.39
Nov 200.39
Nov 200.94
EV/EBITDA
0246med 0.56Jan 23Feb 23Oct 24Nov 24Nov 24Dec 24
PLPL EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 240.01
Dec 240.29
Dec 240.42
Dec 240.29
Nov 240.42
Nov 240.42
Nov 240.29
Nov 240.29
Nov 240.29
Oct 240.42
Oct 240.56
Oct 240.42
Oct 240.56
Mar 234.52
Mar 233.05
Feb 232.32
Feb 232.32
Feb 232.32
Feb 232.32
Jan 232.32
Jan 232.32
Jan 232.32
Jan 232.69
Dec 222.34
Price/Operating Cashflow
00.20.40.6med 0.43Oct 24Oct 24Nov 24Nov 24Nov 24Dec 24Dec 24
PLPL Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 240
Dec 240.29
Dec 240.43
Dec 240.29
Nov 240.43
Nov 240.43
Nov 240.29
Nov 240.29
Nov 240.29
Oct 240.43
Oct 240.57
Oct 240.43
Oct 240.57
Plandaí Biotechnology, Inc.
PLPL
Stockpicker

Video analysis: PLPL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.